DoD FY15 Neuromusculoskeletal Injuries Award

The summary for the DoD FY15 Neuromusculoskeletal Injuries Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD FY15 Neuromusculoskeletal Injuries Award: The FY15/16 JPC-8/CRMRP Neuromusculoskeletal Injuries Research Award (NMSIRA) is intended to support preclinical research and clinical trials on the reintegration after injury, functional utility of assistive devices related to the human-device interface, secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for patients with neuromusculoskeletal injury.
To meet the intent of the award mechanism, applications must specifically address one or more of the FY15/16 JPC-8/CRMRP NMSIRA Focus Areas listed below. Applications proposing research outside of the Focus Areas listed below should not be submitted in response to this Program Announcement/Funding Opportunity.
- Limited capability to assess and facilitate the optimal restoration of physical and psychosocial reintegration following neuromusculoskeletal injury
Lack of efficacious social support strategies
Limited innovative technologies for interconnectivity
Lack of demonstrable methods and technologies to assist and promote lifelong wellness and improved quality of life
Limited validated methods that assess and facilitate effective return to desired real-world functional performance
- Current assistive technology, including prosthetic and orthotic, characteristics that limit patient interaction, usability and durability
Lack of proprioceptive and other sensory inputs that inhibit functional use and safety
Lack of intuitive user intent control for functional use of assistive devices
Lack of device interoperability between available and future components that limits functional potential of multi-joint systems
Lack of human-device interface to address limb health, comfort, and function
- Limited ability to predict, identify, and reduce secondary health effects that develop after primary neuromusculoskeletal injury
Inability to determine factors that predict development and successful treatment of osteoarthritis, low back pain, or other musculoskeletal conditions
Limited intervention strategies to diminish risk of falls
Limited intervention strategies to decrease risk of fractures
Limited strategies to prevent chronic comorbidities such as obesity, cardiovascular disease, and diabetes
- Limited understanding of the optimal treatment strategies and sequence of progression throughout the rehabilitation process following neuromusculoskeletal injury, to include sprains and strains
Inadequate evidence to determine the optimal dose, timing, frequency, duration, setting, and use of innovative rehabilitative techniques to minimize impairments, maximize function and performance, and/or achieve optimal quality of life
- Inadequate measures for standardized assessment of relevant activity performance and participation
Lack of validated metrics that effectively predict function following neuromusculoskeletal injury
Limited number of validated metrics that effectively quantify changes that result from rehabilitation or provision of novel technologies
Lack of quantifiable and functional objective standards for discharge from clinical care